Those under the age of 55 who receive the first dose of estrogenica against Kovid-19 should have a second dose of the messenger RNA vaccine (Pfizer or Modernna), the High Authority for Health (HAS) recommended Friday.
HAS said it was related to 533,000 people in France. The High Authority for Health has discontinued the vaccine Astrogenica For those under 55 on March 19 due to rare thrombosis cases in Europe.
dose ud83d udd34 High Authority of Health “Recommends for people who have received the 1st dose of the estrogen, messenger RNA vaccine for the second dose” pic.twitter.com/x2fNOu8Vox
– BFMTV (@BFMTV) April 9, 2021
But previously, some, especially caregivers, injected the first dose of this vaccine from early February.
HAS also predicted Vaccination strategy French “related” to the British variant of the coronavirus, now the majority in France.
For the South African variant, HAS recommends a different approach
With regard to the South African variant, HAS recommends a different approach as it is more broadcast in some territories.
For foreign units, logistical issues also arise, which recommend the specific use of mRNA vaccines.
For Moselle, she recommended that Jansen be added when the vaccine is available.
Health Minister Oliver Warren indicated this Friday morning that the High Health Authority was about to announce that those under the age of 55 would receive another vaccine than the second dose of estrogen.